Christopher E. Martin1 article listing Christopher E. Martin in Nature Communications, indexed by Paperzzz from Crossref and OSF.TSCM-predominant allogeneic anti-BCMA CAR-T therapy for relapsed/refractory multiple myeloma: preclinical characterization and interim results from a phase 1 trial Nature Communications